Hematologic Malignancies
News
Eye Hemorrhage Signals Myeloid Leukemia
Clinicians observe, diagnose, and treat a patient who displayed symptoms of one of the “most striking findings” in leukemia.
News
Rare type of MCL mimics Castleman disease
Careful flow cytometric analysis is recommended when a histopathological diagnosis is made.
News
FDA Approves Treatment for Chronic GVHD
Ibrutinib has been approved by the FDA for a new usage, treatment of adults with chronic graft versus host disease.
News
Do Post-Transplant Tests Show Recurring Multiple Myeloma?
Researchers question the meaning of oligoclonal patterns in patients who have received stem cell therapy for multiple myeloma.
News
FDA Approves New Leukemia Treatments
Three new drugs have been approved by the FDA for patients with acute leukemia types and show promising remission rates.
News
FDA approves first gene therapy – tisagenlecleucel for ALL
“New technologies such as gene and cell therapies hold out the potential to transform medicine and create an inflection point in our ability to...
Patient Care
The Challenges of Precision Medicine and New Advances in Molecular Diagnostic Testing in Hematolymphoid Malignancies: Impact on the VHA
The Hematopathology Molecular Genetics subcommittee presents recommendations for molecular diagnostic testing in acute myeloid leukemia,...
Article
Which Acute Myeloid Leukemia Patients are Good Immunotherapy Candidates?
Researchers assess how patients’ immune systems respond to a flu vaccine after chemotherapy to determine the likelihood of positive immunotherapy...
Conference Coverage
Evaluation of Fitness, Metabolism, and Quality of Life During Hematopoietic Stem Cell Transplant
Conference Coverage
Characterization of Hematology Consults for Complete Blood Count Abnormalities: A Single Center Experience in the Era of Electronic Consultation
Abstract 2: 2017 AVAHO Meeting